| Literature DB >> 32032360 |
David A Reynolds1, Mi-Jeong Yoo2, Danielle L Dixson3, Cliff Ross1.
Abstract
As reef-building corals are increasingly being exposed to persistent threats that operate on both regional and global scales, there is a pressing need to better understand the complex processes that diminish coral populations. This study investigated the impacts of the Florida red tide dinoflagellate Karenia brevis and associated brevetoxins on selected facets of coral biology using Porites astreoides as a model system. When provided with choice assays, P. astreoides larvae were shown to actively avoid seawater containing red tide (5×105 cells L-1-7.6×106 cells L-1) or purified brevetoxins (0.018 μg mL-1 brevetoxin-2 and 0.0018 μg mL-1 brevetoxin-3). However, forced exposure to similar treatments induced time-dependent physiological and behavioral changes that were captured by PAM fluorometry and settlement and survival assays, respectively. Adult fragments of P. astreoides exposed to red tide or associated brevetoxins displayed signs of proteomic alterations that were characterized by the use of an iTRAQ-based quantitative proteomic analysis. The novel use of this technique with P. astreoides demonstrated that protein regulation was highly contingent upon biological versus chemical treatment (i.e. live K. brevis vs. solely brevetoxin exposure) and that several broad pathways associated with cell stress were affected including redox homeostasis, protein folding, energy metabolism and reactive oxygen species production. The results herein provide new insight into the ecology, behavior and sublethal stress of reef-building corals in response to K. brevis exposure and underscore the importance of recognizing the potential of red tide to act as a regional stressor to these important foundation species.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32032360 PMCID: PMC7006924 DOI: 10.1371/journal.pone.0228414
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Percent time Porites astreoides larvae spent in a channel when introduced to a pairwise choice between two water sources of ambient seawater and a biological cue.
Trials consisted of seawater containing either Karenia brevis cells that represented medium (5 × 105 cells L-1) and high (2.5 × 106 cells L-1, 3.8 × 106 cells L-1 and 7.6 × 106 cells L-1) bloom densities; or brevetoxins at 0.018 μg mL-1 PbTx-2 and 0.0018 μg mL-1 PbTx-3. The brevetoxin seawater control contained methanol at a concentration of 0.0004% v/v. “*” indicates p < 0.001 via Kolmogorov Smirnov test when compared to control trials of ambient seawater vs. ambient seawater. Bars represent + 1 SE.
Fig 2Maximum quantum yield of in hospite Symbiodiniaceae within Porites astreoides tissue following exposure to Karenia brevis or brevetoxins: (A) Porites astreoides larvae, (B) Porites astreoides adults. MeOH = methanol, PbTx = brevetoxin. Bars represent + 1 SE.
Fig 3Kinetics of larval settlement and survival following exposure to either ambient seawater, methanol (MeOH), brevetoxins (PbTx) or Karenia brevis; for either 24, 48 and 72-hours: (A) percent survival, and (B) percent settlement. Bars represent ± 1 SE.
Fig 4Venn diagram of differentially concentrated proteins among treatments.
A total of 52, 15 and 28 proteins were significantly up- or downregulated in Karenia brevis, brevetoxin (PbTx) and methanol (MeOH) treatments, respectively.
List and annotation of 61 differentially concentrated proteins of the coral species Porites astreoides following exposure to brevetoxins (PbTx) or Karenia brevis cells.
Proteins in colored cells indicate either upregulated (red) or downregulated (blue) compared to control samples. FC represents fold change in treated samples relative to control samples. Bold indicates sequences from Symbiodiniaceae. Listed p-values are associated with Fisher’s exact test.
| Gene ID | Accession # | Sequence Description | PbTx | |||
|---|---|---|---|---|---|---|
| FC | p-value | FC | p-value | |||
| Cluster599840 | ---Not Available--- | ---Not Available--- | 0.18 | 0.0322 | 1.64 | 0.2997 |
| Cluster45626 | gi|1176095254 | actin-related protein 2 | 1.56 | 0.0219 | 0.40 | 0.0131 |
| Cluster30 | gi|156221418 | predicted protein | 1.57 | 0.0308 | 11.32 | 0.0041 |
| Cluster78396 | gi|1176105383 | uncharacterized skeletal organic matrix protein 5-like | 11.00 | 0.0494 | 9.72 | 0.0467 |
| Cluster153015 | gi|1191069530 | uncharacterized protein LOC110251054 | 5.23 | 0.0000 | 3.31 | 0.0000 |
| Cluster97665 | gi|1176107158 | failed axon connections homolog | 4.64 | 0.0112 | 3.02 | 0.0378 |
| Cluster78285 | gi|1176094913 | neurogenic locus Notch protein-like | 1.63 | 0.0074 | 2.53 | 0.0000 |
| Cluster74461 | gi|1005492381 | histone H2A-like | 1.71 | 0.0242 | 1.56 | 0.5163 |
| 2.12 | 0.0161 | 1.34 | 0.2022 | |||
| Cluster120960 | gi|156384837 | histone H4-like | 2.02 | 0.0000 | 1.30 | 0.4262 |
| Cluster54901 | gi|134104063 | chloroplast soluble peridinin-chlorophyll a-binding protein precursor | 1.74 | 0.0000 | 1.29 | 0.0016 |
| Cluster92319 | gi|156308410 | histone H2B | 3.02 | 0.0128 | 1.12 | 0.1788 |
| Cluster42011 | gi|1176106978 | trichohyalin-like isoform X2 | 1.72 | 0.0282 | 1.08 | 0.9878 |
| Cluster201619 | gi|1005436313 | Calreticulin | 1.61 | 0.0215 | 0.80 | 0.0633 |
| Cluster480843 | ---Not Available--- | ---Not Available--- | 1.85 | 0.0274 | 0.59 | 0.0190 |
| Cluster12861 | gi|1176065290 | vacuolar protein sorting-associated protein 35 | 1.05 | 0.0226 | 0.49 | 0.0000 |
| Cluster86218 | gi|1005455133 | centromere-associated protein E-like | 1.06 | 0.2853 | 0.48 | 0.0207 |
| Cluster77817 | gi|1176083360 | thiosulfate sulfurtransferase-like | 1.30 | 0.2002 | 0.47 | 0.0483 |
| Cluster70872 | gi|1176102334 | 6-phosphogluconate dehydrogenase, decarboxylating-like | 1.31 | 0.1303 | 0.45 | 0.0492 |
| Cluster44622 | gi|1176099874 | protein kinase C and casein kinase substrate in neurons protein 1 isoform X3 | 1.22 | 0.2016 | 0.44 | 0.0437 |
| Cluster36510 | gi|1176074793 | 3-phosphoinositide-dependent protein kinase 1 | 1.29 | 0.2687 | 0.43 | 0.0460 |
| Cluster14994 | gi|1176081911 | spermatogenesis-associated protein 20 | 0.96 | 0.3760 | 0.42 | 0.0433 |
| Cluster38861 | gi|514686106 | hypothetical protein PTSG_08380 | 1.38 | 0.2078 | 0.41 | 0.0404 |
| Cluster39017 | gi|1263131715 | Trifunctional enzyme subunit beta, mitochondrial | 0.93 | 0.1247 | 0.40 | 0.0029 |
| Cluster90375 | gi|1005435074 | proteasomal ubiquitin receptor ADRM1-like | 0.72 | 0.1822 | 0.40 | 0.0396 |
| Cluster72289 | gi|1005478902 | prohibitin-2 isoform X1 | 1.37 | 0.1582 | 0.38 | 0.0403 |
| Cluster13855 | gi|1176083171 | centrosomal protein of 290 kDa-like | 0.79 | 0.0213 | 0.36 | 0.0082 |
| 1.22 | 0.1645 | 0.33 | 0.0359 | |||
| Cluster77998 | gi|1176061994 | Krueppel-like factor 16 | 1.14 | 0.2920 | 0.32 | 0.0214 |
| Cluster135790 | gi|1005469133 | Seed maturation protein domain protein | 0.87 | 0.0882 | 5.46 | 0.0194 |
| Cluster563359 | gi|999976565 | succinate--CoA ligase (ADP/GDP-forming) subunit alpha, mitochondrial-like | 0.92 | 0.5393 | 2.99 | 0.0236 |
| Cluster12612 | gi|156224519 | Endoplasmin | 1.25 | 0.2646 | 2.73 | 0.0000 |
| Cluster6698 | gi|999985476 | NAD(P) transhydrogenase, mitochondrial | 1.13 | 0.7138 | 2.69 | 0.0019 |
| Cluster8701 | gi|1176081387 | cleavage stimulation factor subunit 2-like | 1.06 | 0.3771 | 2.65 | 0.0355 |
| Cluster110390 | gi|931444489 | metal-dependent hydrolase | 1.41 | 0.0079 | 2.56 | 0.0058 |
| Cluster665 | ---Not Available--- | ---Not Available--- | 1.05 | 0.3370 | 2.55 | 0.0155 |
| 0.71 | 0.2976 | 2.49 | 0.0479 | |||
| Cluster3401 | gi|828223890 | THO complex subunit 2 | 0.87 | 0.3766 | 2.46 | 0.0322 |
| Cluster71042 | gi|156376666 | heterogeneous nuclear ribonucleoprotein A/B isoform X1 | 0.98 | 0.4789 | 2.46 | 0.0406 |
| Cluster137452 | gi|1005485438 | myosin-2 essential light chain-like | 1.19 | 0.1023 | 2.43 | 0.0008 |
| Cluster68537 | gi|1176073868 | cartilage matrix protein-like | 1.21 | 0.1569 | 2.43 | 0.0000 |
| Cluster1877 | gi|1176099008 | Intersectin-1 | 1.37 | 0.1259 | 2.33 | 0.0111 |
| Cluster60925 | gi|1263126539 | Cathepsin B | 1.32 | 0.3480 | 2.28 | 0.0013 |
| Cluster89694 | gi|1270045038 | Proteasome subunit alpha type-5 | 1.11 | 0.8611 | 2.18 | 0.0125 |
| Cluster63543 | gi|1176121623 | cathepsin L1-like | 1.00 | 0.7961 | 2.18 | 0.0346 |
| Cluster80745 | gi|1176123940 | cytochrome b-c1 complex subunit Rieske, mitochondrial-like | 1.17 | 0.8346 | 1.94 | 0.0001 |
| Cluster24085 | gi|944358134 | Tubulin alpha-1C chain | 0.83 | 0.8934 | 1.91 | 0.0291 |
| Cluster29482 | gi|1270036269 | glucosidase 2 subunit beta-like | 0.91 | 0.3125 | 1.91 | 0.0448 |
| Cluster10800 | gi|156219690 | coatomer subunit gamma-2 | 0.66 | 0.0663 | 1.90 | 0.0005 |
| Cluster98716 | gi|1176090182 | ras-related protein Rab-11A | 1.01 | 0.6742 | 1.90 | 0.0098 |
| Cluster40025 | gi|1263121217 | Protein disulfide-isomerase A6 | 1.07 | 0.5999 | 1.82 | 0.0031 |
| Cluster101211 | gi|1176117806 | glutathione S-transferase-like | 0.83 | 0.6735 | 1.73 | 0.0023 |
| Cluster136968 | gi|1176092520 | neuronal pentraxin-2-like | 1.26 | 0.1302 | 1.72 | 0.0289 |
| Cluster111088 | gi|1005447951 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 8, mitochondrial | 1.61 | 0.1944 | 1.71 | 0.0095 |
| Cluster58031 | gi|1263138886 | protein disulfide-isomerase tigA precursor | 0.97 | 0.8207 | 1.70 | 0.0065 |
| Cluster41678 | gi|1005486638 | phosphatidylserine decarboxylase | 1.00 | 0.7788 | 1.68 | 0.0018 |
| Cluster5009 | gi|1176107568 | dyp-type peroxidase family protein | 1.03 | 0.0076 | 1.64 | 0.0010 |
| Cluster15920 | gi|1176120735 | predicted protein | 1.08 | 1.0000 | 1.57 | 0.0133 |
| Cluster32856 | gi|1176110238 | protein disulfide isomerase | 1.22 | 0.2482 | 1.56 | 0.0060 |
| Cluster225948 | gi|1101333444 | fructose-bisphosphate aldolase | 0.87 | 0.0222 | 1.52 | 0.0000 |
| Cluster20910 | gi|749717734 | Transposon Tf2-6 polyprotein | 0.94 | 0.0713 | 1.52 | 0.0002 |
Fig 5Venn diagram showing the number of differentially concentrated proteins in Porites astreoides tissue following exposure to red tide and associated brevetoxins: (A) total number of differentially concentrated proteins in brevetoxin (PbTx) or Karenia brevis treatments; and (B) proteins grouped into up- or downregulated categories in response to brevetoxin or Karenia brevis treatments.
Fig 6Enrichment bar charts of differentially concentrated proteins in Porites astreoides as a function of treatment: (A) 15 differentially concentrated proteins in brevetoxin-treated samples relative to controls, (B) 52 differentially concentrated proteins in Karenia brevis-treated samples compared to controls. BP, CC and MF represent biological process, cellular component and molecular function, respectively.